Exelon (NASDAQ:EXC – Get Free Report) was downgraded by Mizuho from a “strong-buy” rating to a “hold” rating in a note issued to investors on Friday,Zacks.com reports.
EXC has been the subject of a number of other research reports. Citigroup initiated coverage on Exelon in a report on Thursday, March 26th. They issued a “buy” rating and a $58.00 price objective for the company. Barclays downgraded Exelon from an “overweight” rating to an “equal weight” rating and reduced their price target for the company from $50.00 to $49.00 in a report on Friday. Royal Bank Of Canada started coverage on Exelon in a report on Wednesday, January 7th. They set a “sector perform” rating and a $51.00 price target for the company. Wells Fargo & Company raised their price target on Exelon from $51.00 to $53.00 and gave the company an “overweight” rating in a report on Friday, February 13th. Finally, Jefferies Financial Group reduced their price target on Exelon from $57.00 to $55.00 and set a “buy” rating for the company in a report on Tuesday, January 27th. Six investment analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $51.00.
Check Out Our Latest Report on EXC
Exelon Price Performance
Exelon (NASDAQ:EXC – Get Free Report) last posted its quarterly earnings data on Thursday, February 12th. The company reported $0.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.55 by $0.04. Exelon had a return on equity of 9.97% and a net margin of 11.41%.The business’s quarterly revenue was down 1.1% compared to the same quarter last year. During the same period in the prior year, the business earned $0.64 earnings per share. Exelon has set its FY 2026 guidance at 2.810-2.910 EPS. Research analysts predict that Exelon will post 2.64 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Exelon
Several institutional investors and hedge funds have recently modified their holdings of EXC. Capital International Investors bought a new position in shares of Exelon during the fourth quarter valued at $738,333,000. Norges Bank purchased a new stake in shares of Exelon during the fourth quarter valued at $617,974,000. Capital World Investors boosted its position in shares of Exelon by 807.4% during the fourth quarter. Capital World Investors now owns 10,100,575 shares of the company’s stock valued at $440,284,000 after buying an additional 8,987,453 shares during the last quarter. Lazard Asset Management LLC boosted its position in shares of Exelon by 32.9% during the third quarter. Lazard Asset Management LLC now owns 22,446,103 shares of the company’s stock valued at $1,010,299,000 after buying an additional 5,554,494 shares during the last quarter. Finally, ANTIPODES PARTNERS Ltd boosted its position in shares of Exelon by 134,604.0% during the third quarter. ANTIPODES PARTNERS Ltd now owns 3,557,532 shares of the company’s stock valued at $160,137,000 after buying an additional 3,554,891 shares during the last quarter. 80.92% of the stock is currently owned by institutional investors.
Key Stories Impacting Exelon
Here are the key news stories impacting Exelon this week:
- Positive Sentiment: Argus reiterated a Buy on EXC and raised its price target to $52, highlighting the company’s solid recent results and projected growth — a direct positive catalyst for investor sentiment. Exelon Corporation (EXC) A Top Utility Stock Projecting Robust Growth
- Neutral Sentiment: Federal support for low‑carbon energy (reports that the administration will preserve billions for hydrogen ventures) could benefit the broader clean‑energy sector over time, but the near‑term impact on Exelon is indirect and uncertain. Trump set to preserve billions of dollars in funding for hydrogen ventures
- Neutral Sentiment: Several media pieces suggest investors might add EXC to watchlists based on valuation and utility sector dynamics, reflecting interest but not an immediate catalyst. Is Now The Time To Put Exelon (NASDAQ:EXC) On Your Watchlist?
- Negative Sentiment: Multiple major brokers (Barclays, BMO and Mizuho) downgraded EXC roughly the same day, citing regulatory uncertainty and fewer near‑term catalysts — a coordinated analyst pullback that is pressuring the share price. Exelon Gets Hit With a Triple Downgrade From Barclays, BMO and Mizuho
- Negative Sentiment: Barclays cut EXC from Overweight to Equal Weight and trimmed its price target to $49, signaling limited upside in the near term and contributing to selling pressure. Exelon (EXC) was downgraded to a Hold Rating at Barclays
- Negative Sentiment: BMO Capital lowered its rating citing regulatory headwinds and scarce catalysts, reinforcing the bearish analyst tone. BMO Capital downgrades Exelon (EXC)
- Negative Sentiment: Mizuho downgraded Exelon from Strong‑Buy to Hold, adding to the cluster of downgrades and likely boosting intraday volume and selling. Zacks coverage of Mizuho downgrade
About Exelon
Exelon Corporation (NASDAQ: EXC) is a Chicago-based energy company that operates primarily as a regulated electric and natural gas utility holding company. The company’s businesses focus on the delivery of electricity and related services to residential, commercial and industrial customers, as well as investments in grid modernization, customer energy solutions and demand-side programs. Exelon’s operations emphasize reliable service delivery, infrastructure maintenance and regulatory compliance across its utility footprint.
Formed in 2000 through the merger of Unicom and PECO Energy, Exelon historically combined generation and regulated utility businesses.
Featured Articles
Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.
